PROGRAM MANAGEMENT AGREEMENT between Tower Insurance Company of New York and CastlePoint Management Corp. Amended and RestatedProgram Management Agreement • March 31st, 2008 • CastlePoint Holdings, Ltd. • Fire, marine & casualty insurance • New York
Contract Type FiledMarch 31st, 2008 Company Industry JurisdictionThis Agreement, entered into as of January 1, 2007 (the “Agreement”) by and between TOWER INSURANCE COMPANY OF NEW YORK, a property and casualty insurance company domiciled in New York (the “Company”), and CASTLEPOINT MANAGEMENT CORP., a Delaware corporation (“Manager”), each having offices located at 120 Broadway, New York, N.Y. 10271.
MEMORANDUM OF AGREEMENTAggregate Excess of Loss Agreement • March 31st, 2008 • CastlePoint Holdings, Ltd. • Fire, marine & casualty insurance • New York
Contract Type FiledMarch 31st, 2008 Company Industry JurisdictionThe attached Aggregate Excess of Loss Agreement has been submitted for regulatory approval. The participating companies below have agreed to the attached Aggregate Excess of Loss Agreement pending regulatory approval.
SERVICE AGREEMENTService Agreement • March 31st, 2008 • CastlePoint Holdings, Ltd. • Fire, marine & casualty insurance • Delaware
Contract Type FiledMarch 31st, 2008 Company Industry JurisdictionThis (“Agreement”) is entered into as of May 1, 2007 by and between Tower Risk Management Corp.(“TRM”), a company domiciled in New York with offices located at 120 Broadway, New York, N.Y. 10271 and CastlePoint Management Corp. (“CPM”), a Delaware corporation with offices located at 120 Broadway, New York, N.Y. 10271.
MEMORANDUM OF AGREEMENTBrokerage Business Quota Share Reinsurance Agreement • March 31st, 2008 • CastlePoint Holdings, Ltd. • Fire, marine & casualty insurance
Contract Type FiledMarch 31st, 2008 Company IndustryThe attached Amendment No. 4 to the Amended & Restated Brokerage Business Quota Share Reinsurance Agreement has been submitted for regulatory approval. The participating companies below have agreed to the attached Amendment No. 4 pending regulatory approval.